China NMPA Approves Bio-Thera Solutions’ BAT1806, A Biosimilar to Actemra® (Tocilizumab)
World’s First Approved Biosimilar to Actemra® GUANGZHOU, China--(BUSINESS WIRE)--#Actemra--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage…
World’s First Approved Biosimilar to Actemra® GUANGZHOU, China--(BUSINESS WIRE)--#Actemra--Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage…
DUBLIN--(BUSINESS WIRE)--The "Japan Lawn Mowers Market Analysis & Growth Forecast 2022-2027" report has been added…
Chapter to host inaugural Tokyo event on January 18 discussing climate risk JERSEY CITY, N.J.--(BUSINESS…
Delivering up to 30 results from a single drop of body fluid, whether blood, serum,…
HONG KONG SAR AND TAIWAN - Media OutReach - 16 January 2023 - The Sandbox,…
The workshop for autistic children and their parents is part of FWD’s social inclusion initiative…
SHENZHEN, CHINA - Media OutReach - 16 January 2023 - On the evening of January…
Full-year 2022 operating income exceeds NT$100bn with automotive revenue up 82% YoY Fourth Quarter 2022…
IEEE P1901c WG adopts baseline specification for next-generation standard. FUKUOKA, Japan--(BUSINESS WIRE)--#ieee--HD-PLC Alliance (“Alliance”) announced…
Consumers can expect to enjoy lab-grown unagi and other fishes as early as 2024 SINGAPORE…